Withdrawal of antiepileptic drugs in people with non-epileptic seizures

Ring, H. A.
December 2005
Journal of Neurology, Neurosurgery & Psychiatry;Dec2005, Vol. 76 Issue 12, p1613
Academic Journal
This article discusses the withdrawal of antiepileptic drugs in people with non-epileptic seizures (NES). NES substantially disturb the health and well being of the people suffering from them. The treatment costs of undiagnosed NES is almost equal to the lifetime costs associated with the treatment of intractable epilepsy. Appropriate diagnosis of this dreadful diseases plays a crucial role in it's treatment. Significant reductions in medical costs and health-care utilization rates have been reported to follow appropriate diagnosis and management of the patients suffering from this diseases.


Related Articles

  • EEG -- Infantile Spasms. McGlannan, Frances; Watanabe, Kazuyoshi; Iwase, Katsuhiko; Hara, Kimiko // Journal of Learning Disabilities;Apr1974, Vol. 7 Issue 4, p212 

    This article reports on a study which described the developmental course of infantile spasms and hypsarrhythmia. It has been generally accepted that infantile spasms are not a disease entity, but are an age-specific response of the infant brain, and that the characteristic...

  • JOURNAL SHORTCUTS RECENT PAPERS ON EPILEPSY. Rogers, Greg // Pulse;4/20/2006, Vol. 66 Issue 16, p46 

    The article presents abstracts of epilepsy research and discusses their clinical implications. They include "Evaluation of health status in epilepsy using the EQ-5D questionnaire: a prospective, observational, six-month study of adjunctive therapy with anti-epileptic drugs," "Immediate versus...

  • Influence of ethanol on the threshold for electroshock-induced seizures and electrically-evoked hippocampal afterdischarges. Fischer, W. // Journal of Neural Transmission;Sep2005, Vol. 112 Issue 9, p1149 

    The anticonvulsant activity of ethanol was investigated in two representative models of experimental epilepsy. In the maximal electroshock seizure threshold test in mice, ethanol (0.5–2 g/kg i.p.) dose-dependently raised the electroconvulsive threshold for tonic seizures. In co-medication...

  • Catamenial Epilepsy: A Case Report. Shrestha, Isha Dhungana // Nepal Journal of Neuroscience;2012, Vol. 9 Issue 2, p76 

    Seizure disorder associated with menstrual cycles of a female patient is termed as catamenial epilepsy. Though the terminology has been in use since the ancient time, no case has been reported in Nepal. Here we report a case of an 18 year old lady, who has been having seizures for last 5 years,...

  • Endocannabinoids and Their Implications for Epilepsy. Alger, Bradley E. // Epilepsy Currents;Sep/Oct2004, Vol. 4 Issue 5, p169 

    This review covers the main features of a newly discovered intercellular signaling system in which endogenous ligands of the brain's cannabinoid receptors, or endocannabinoids, serve as retrograde messengers that enable a cell to control the strength of its own synaptic inputs. Endocannabinoids...

  • Comparative Monotherapy Trials and the Clinical Treatment of Epilepsy. Abou-Khalil, Basel W. // Epilepsy Currents;Sep2007, Vol. 7 Issue 5, p127 

    Brodie MJ, Perucca E, Ryvlin P, Ben-Menachem E, Meencke HJ; Levetiracetam Monotherapy Study Group. Neurology 2007;68(6):402–408. OBJECTIVE: We report the results of a prospective study of the efficacy and tolerability of levetiracetam, a new antiepileptic drug with a unique mechanism of...

  • Topics in Neurology: Advances in managing epilepsy. Karceski, Steven C.; Kelley, Roger E.; Schachter, Steven C. // Patient Care for the Nurse Practitioner;Feb2005, Vol. 8 Issue 2, p4 

    The article offers clinical information on epilepsy. More than 2.5 million people in the U.S. and over 50 million worldwide suffer from epilepsy. The ultimate goal in the clinical management of epilepsy is seizure free without side effects. Although most people with epilepsy become seizure free...

  • Extended-Release Formulations for the Treatment of Epilepsy. Bialer, Meir // CNS Drugs;2007, Vol. 21 Issue 9, p765 

    This review analyses the concept of extended-release (ER) formulations in epilepsy and evaluates ER formulations of carbamazepine, valproic acid and a modified-release (MR) formulation of oxcarbazepine. ER formulations are usually designed to reduce dose frequency and maintain relatively...

  • Advances in the Treatment of Epilepsy. Benbadis, Selim R.; Tatum IV, William O. // American Family Physician;7/1/2001, Vol. 64 Issue 1, p91 

    Significant advances have been made in the diagnosis and treatment of epilepsy over the past decade. With the advent of electroencephalographic video monitoring, physicians are now able to reliably differentiate epilepsy from other conditions that can mimic it, such as pseudoseizures. In...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics